ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Researchers report promising outcomes from clinical trial in patients with … – News-Medical.net

Continue reading

2014-12-08 Michael Zand NEWS

Stem cells hold new hope for baldness – The Hindu

Researchers report promising outcomes from clinical trial in patients with …
News-Medical.net
Researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic stem cell transplant (HSCT) after …

and more »

Continue reading

2014-12-08 Michael Zand NEWS

Stem Cell Transplant Feasible, Highly Effective for HIV-Associated Lymphoma – OncLive

OncLiveStem Cell Transplant Feasible, Highly Effective for HIV-Associated LymphomaOncLivePatients with HIV-associated lymphoma can effectively be treated with autologous hematopoietic stem cell transplantation (AHCT), with outcomes that are similar to … Continue reading

2014-12-08 Michael Zand NEWS

NFL Players Getting Stem Cell Treatments – Live Trading News


The Hindu

Stem cells hold new hope for baldness
The Hindu
New procedures are being evolved in different therapies and surgical methods to extend the benefits of stem cell research and its applications to the needy people with better and effective results. “This has not only revolutionised bio-technology …

Continue reading

2014-12-08 Michael Zand NEWS

Stem cell transplant without radiation or chemotherapy pre-treatment shows … – Medical Xpress

NFL Players Getting Stem Cell Treatments
Live Trading News
“With the rise of new and unproven Stem Cell treatments, the NFL faces a daunting task of trying to better understand and regulate the use of these therapies in order to protect the health of its players,” said Kirstin Matthews, an expert on ethical …
The female sex hormones protect against some leukemiasBeta Wired

all 2 news articles »

Continue reading

2014-12-07 Michael Zand NEWS

Stem cell transplant without radiation or chemotherapy pre-treatment shows … – EurekAlert (press release)

Stem cell transplant without radiation or chemotherapy pre-treatment shows …
Medical Xpress
Researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic stem cell transplant (HSCT) after …

and more »

Continue reading

2014-12-07 Michael Zand NEWS

Stem cell transplant without radiation or chemotherapy pre-treatment shows … – EurekAlert (press release)

Stem cell transplant without radiation or chemotherapy pre-treatment shows …
EurekAlert (press release)
SAN FRANCISCO (DECEMBER 7, 2014) – Researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic …

and more »

Continue reading

2014-12-07 Michael Zand NEWS

Unproven Stem Cell Treatment Faces Controversy – NBCNews.com

NBCNews.comUnproven Stem Cell Treatment Faces ControversyNBCNews.comNightly News An NBC News investigation found that some patients are turning to a controversial stem cell therapy that many experts say has no proven benefit. Published December 5th … Continue reading

2014-12-07 Michael Zand NEWS
  • 1
  • …
  • 2,964
  • 2,965
  • 2,966
  • 2,967
  • 2,968
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Stem cell transplant without radiation or chemotherapy pre-treatment shows …
EurekAlert (press release)
SAN FRANCISCO (DECEMBER 7, 2014) – Researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic …

and more »